Company: CLX
Filing Date: 2025-10-07
Form Type: DEF 14A
Source: 0001552781-25-000311
Chunk: 19

Company: CLOROX CO /DE/
Filing Date: 2025-10-07
Form: DEF 14A
Chunk 19
---
 were 121,683,474 shares of common stock outstanding. |

| (4) | Based                                                                                                                               
 on information contained in a report on Schedule 13G/A filed with the SEC on February 13, 2024, The Vanguard Group reported, as of  
 December 29, 2023, sole dispositive power with respect to 14,672,619 shares, shared voting power with respect to 164,013 shares and 
 shared dispositive power with respect to 556,279 shares.                                                                            |

| (5) | Based                                                                                                                            
 on information contained in a report on Schedule 13G/A filed with the SEC on July 17, 2025, BlackRock, Inc. reported, as of June 
 30, 2025 sole voting power with respect to 8,960,192 shares and sole dispositive power with respect to all shares reported.      |

| (6) | Based                                                                                                                                
 on information contained in a report on Schedule 13G/A filed with the SEC on January 25, 2024, State Street Corporation reported,    
 as of December 31, 2023, shared voting power with respect to 5,329,376 shares and shared dispositive power with respect to 8,401,550 
 shares.                                                                                                                              |

| (7) | Mr.                                                                                                                         
 Fleischer is not being renominated for re-election in accordance with the Board’s retirement policy and, therefore, will be 
 retiring from the Board as of the date of the Annual Meeting.                                                               |

| (8) | On                                                                                                                                   
 September 4, 2025, Mr. Reynolds acquired 15,210 shares through a stock option exercise and sold 15,041 shares, as reported on a Form 
 4 filed with the SEC on September 8, 2025.                                                                                           |

| (9) | Pursuant                                                                                                                          
 to Rule 3b-7 of the Securities Exchange Act of 1934, as amended (Exchange Act), executive officers include the Company’s CEO      
 and all executive vice presidents. The figure reflects ownership, as of August 31, 2025, of the executive officers as of the date 
 of this proxy statement, who are set forth in the Executive Officers section of this proxy statement.                             |

| The                                                          
 Clorox Company 2025 Proxy Statement > Executive Compensation | 43 |

Executive Compensation Proposal 2: Advisory Vote to
Approve Executive Compensation

| We                                                                                                                                  
 are